This study is accepting new patients by invitation only

Fecal Microbiota Transplant National Registry

a study on Fecal Microbiota Transplant

Summary

Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by Max Brondfield, MD
Headshot of Max Brondfield
Max Brondfield

Description

Summary

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness. Neonates will not be enrolled at any site for this study. The study data will derive from patient and donors past and present medical records, research records, and records about phone calls made as part of this research. The patient data will also be used from the records on visits.

Keywords

Fecal Microbiota Transplant, FMT

Eligibility

Recipient Inclusion Criteria :

  • Ability to give informed consent
  • Receiving FMT or other gut-related microbiota product within 90 days after providing consent
  • Access to internet and/or telephone

Donor Inclusion Criteria:

  • Ability to give informed consent
  • Providing stool sample for FMT

Exclusion Criteria:

  • Incarceration

Location

  • UCSF
    San Francisco California 94115 United States

Lead Scientist at UCSF

  • Max Brondfield, MD
    Dr. Max Brondfield is an assistant professor in the division of gastroenterology at UCSF in San Francisco. He completed his medical degree, internal medicine residency, chief residency, and fellowship at UCSF. His include celiac disease, functional GI disorders including irritable bowel syndrome, fecal microbiota transplantation, and inflammatory bowel disease.

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06262451
Study Type
Observational [Patient Registry]
Participants
Expecting 10 study participants
Last Updated